Delivery Order SPE2DB22D3501-SPE2DB24FUT56

Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $23K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $27,129.90 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $25,764.80 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) with a potential value of $13,998.66 to provide Activase 100 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA Troop Support Medical, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies in support of military treatment...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,563,748,083 units of ACTIVASE 100 MG VIALS. The contract has a potential value of $17,141.55 and a completion date of February 26, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,864.71 firm fixed price delivery order contract to provide ACTIVASE 50 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ACTIVASE 100 MG VIALS. The contract has a potential value of $17,676.17 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. This delivery order is...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTIVASE 50 MG VIALS. The contract has a ceiling value of $5,729.42 and a performance period through April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The $58,802.81 firm fixed-price contract is for the supply of 4565108834 ACTIVASE 100 MG VIALS. Amerisourcebergen, a leading pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $5,769.87 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 100 mg vials of the pharmaceutical product ACTIVASE. The contract has a firm fixed price and does not utilize any set-aside designations. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products, including ACTIVASE 50MG INJ 1S, to various government agencies. The $2,864.71 Firm Fixed Price delivery order was awarded on June 3, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FUT56
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $23,241.52 by the Defense Logistics Agency (DLA) to provide ACTIVASE 100 MG VIALS. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense, with a potential value of $999,999,999.00 through December 31, 2025. This contract does not have a set-aside designation.

Generated 5/30/24, 9:38 AM